Showing 1 - 8 results of 8 for search '1. FC Union Berlin', query time: 0.14s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Efficacy of rFIXFc versus N9-GP Prophylaxis in Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PARADIGM 2 Trials by Mancuso ME, Eriksson D, Falk A, Hakimi Z, Wojciechowski P, Wdowiak M, Klamroth R

    Published 2023-07-01
    “…Maria Elisa Mancuso,1,2 Daniel Eriksson,3 Aletta Falk,3 Zalmai Hakimi,3 Piotr Wojciechowski,4,5 Marlena Wdowiak,4 Robert Klamroth6,7 1Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy; 2Humanitas University, Pieve Emanuele, Milan, Italy; 3Swedish Orphan Biovitrum AB, Stockholm, Sweden; 4Creativ-Ceutical, Krakow, Poland; 5Assignity, Krakow, Poland; 6Department of Internal Medicine, Hemophilia Treatment Center, Vivantes Klinikum im Friedrichshain, Berlin, Germany; 7Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, GermanyCorrespondence: Robert Klamroth, Department of Internal Medicine – Angiology and Hemostaseology, Center for Vascular Medicine, Haemophilia Treatment Center, Vivantes Klinikum im Friedrichshain, Landsberger Allee 49, Berlin, D-10249, Germany, Tel +49 (0)30 130 231575, Fax +49 (0)30 130 232130, Email robert.klamroth@vivantes.dePurpose: For patients with hemophilia B, extended half-life factor IX (FIX) products are available for prophylaxis and for treating bleeds. …”
    Get full text
    Article
  6. 6
  7. 7
  8. 8